Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SAEED MOHAMMAD

Allopathic & Osteopathic Physicians Pediatrics Pediatric Transplant Hepatology

NPI
1942357736
CMS profile
617934
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$152,778.63

127 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
ALBIREO PHARMA, INC. $59,750.29 58
Mirum Pharmaceuticals, Inc. $46,927.88 50
Ipsen Biopharmaceuticals, Inc $42,500.46 18
Echosens North America, Inc. $3,600.00 1

Page 2 of 3; records 51–100 of 127 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SAEED MOHAMMAD

NPI 1942357736 · CMS profile ID 617934

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Transplant Hepatology

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 127 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1942357736?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SAEED MOHAMMAD, NPI 1942357736, CMS profile ID 617934. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 127 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1942357736?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SAEED MOHAMMAD, NPI 1942357736, CMS profile ID 617934. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 127 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1942357736?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SAEED MOHAMMAD, NPI 1942357736, CMS profile ID 617934, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 127 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1942357736?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

127 matching records · $152,778.63 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 127 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 127.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Mirum Pharmaceuticals, Inc. $48.1908/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983407 CMS
Mirum Pharmaceuticals, Inc. $50.4808/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983411 CMS
Mirum Pharmaceuticals, Inc. $28.0008/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983413 CMS
Mirum Pharmaceuticals, Inc. $5.7408/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983417 CMS
Mirum Pharmaceuticals, Inc. $43.8508/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983419 CMS
ALBIREO PHARMA, INC. $6,462.0008/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056525419 CMS
ALBIREO PHARMA, INC. $8,975.0007/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523659 CMS
ALBIREO PHARMA, INC. $51.4707/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523697 CMS
ALBIREO PHARMA, INC. $57.7207/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523703 CMS
Mirum Pharmaceuticals, Inc. $3,080.0007/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983393 CMS
Mirum Pharmaceuticals, Inc. $39.0807/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983395 CMS
Ipsen Biopharmaceuticals, Inc $1,436.0006/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045461013 CMS
ALBIREO PHARMA, INC. $168.0006/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523723 CMS
ALBIREO PHARMA, INC. $335.7806/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523707 CMS
ALBIREO PHARMA, INC. $168.0006/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523717 CMS
ALBIREO PHARMA, INC. $81.9006/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523731 CMS
ALBIREO PHARMA, INC. $60.9606/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056523737 CMS
ALBIREO PHARMA, INC. $1,436.0006/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527135 CMS
ALBIREO PHARMA, INC. $2,872.0006/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527568 CMS
ALBIREO PHARMA, INC. $14.6506/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527575 CMS
ALBIREO PHARMA, INC. $290.3906/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527579 CMS
Echosens North America, Inc. $3,600.0005/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052147301 CMS
ALBIREO PHARMA, INC. $5,877.0005/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056525331 CMS
ALBIREO PHARMA, INC. $80.0005/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527545 CMS
ALBIREO PHARMA, INC. $129.9805/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527551 CMS
ALBIREO PHARMA, INC. $370.1305/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527556 CMS
ALBIREO PHARMA, INC. $123.9105/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056527561 CMS
Mirum Pharmaceuticals, Inc. $35.4805/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983423 CMS
Mirum Pharmaceuticals, Inc. $1,925.0004/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983390 CMS
ALBIREO PHARMA, INC. $3,949.0004/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526819 CMS
ALBIREO PHARMA, INC. $149.6204/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526825 CMS
ALBIREO PHARMA, INC. $16.6404/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526831 CMS
ALBIREO PHARMA, INC. $80.0003/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526789 CMS
ALBIREO PHARMA, INC. $251.2603/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526795 CMS
ALBIREO PHARMA, INC. $795.6003/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526801 CMS
ALBIREO PHARMA, INC. $321.6203/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526807 CMS
ALBIREO PHARMA, INC. $113.0903/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056526813 CMS
Mirum Pharmaceuticals, Inc. $3,080.0003/09/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983355 CMS
Mirum Pharmaceuticals, Inc. $149.3303/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983357 CMS
Mirum Pharmaceuticals, Inc. $24.0903/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983361 CMS
Mirum Pharmaceuticals, Inc. $4.9203/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983363 CMS
Mirum Pharmaceuticals, Inc. $12.3203/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983367 CMS
Mirum Pharmaceuticals, Inc. $603.8803/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983369 CMS
Mirum Pharmaceuticals, Inc. $28.0003/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983373 CMS
Mirum Pharmaceuticals, Inc. $57.3003/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983375 CMS
Mirum Pharmaceuticals, Inc. $35.5803/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983379 CMS
Mirum Pharmaceuticals, Inc. $3,272.5003/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983381 CMS
Mirum Pharmaceuticals, Inc. $199.2803/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983385 CMS
ALBIREO PHARMA, INC. $22.9203/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056525805 CMS
Mirum Pharmaceuticals, Inc. $3,080.0002/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022983319 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,673.79 12
PY2022 $41,483.14 32
PY2023 $152,778.63 127
PY2024 $101,897.76 87
PY2025 $54,007.65 36

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $120,471.04 19
PY2024 Principal investigator $72,103.40 15
PY2023 Principal investigator $74,378.73 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Mirum Pharmaceuticals, Inc. $3,000.00 12/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159457
Principal investigator 1 Mirum Pharmaceuticals, Inc. $5,600.00 12/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159465
Principal investigator 1 Mirum Pharmaceuticals, Inc. $1,000.00 12/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159469
Principal investigator 1 Mirum Pharmaceuticals, Inc. $7,002.45 12/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159473
Principal investigator 1 Mirum Pharmaceuticals, Inc. $1,818.32 12/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159476
Principal investigator 1 Mirum Pharmaceuticals, Inc. $154.80 12/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159480
Principal investigator 1 ALBIREO PHARMA, INC. $2,787.21 11/13/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT) No dispute reported 06/30/2026 1176479041
Principal investigator 1 ALBIREO PHARMA, INC. $2,538.75 11/12/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT) No dispute reported 06/30/2026 1176479043
Principal investigator 1 ALBIREO PHARMA, INC. $6,427.36 10/14/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT) No dispute reported 06/30/2026 1176479039
Principal investigator 1 Mirum Pharmaceuticals, Inc. $3,000.00 10/03/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159453
Principal investigator 1 Mirum Pharmaceuticals, Inc. $7,048.90 10/03/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159461
Principal investigator 1 ALBIREO PHARMA, INC. $33,217.35 09/11/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT) No dispute reported 06/30/2026 1176479037
Principal investigator 1 Mirum Pharmaceuticals, Inc. $3,000.00 05/15/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159446
Principal investigator 1 Gilead Sciences, Inc. $10,116.00 05/01/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide in Children Adolescents with Chronic Hepatitis B Infection No dispute reported 06/30/2026 1229214080
Principal investigator 1 Gilead Sciences, Inc. $7,000.00 04/15/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide in Children Adolescents with Chronic Hepatitis B Infection No dispute reported 06/30/2026 1229214070
Principal investigator 1 Mirum Pharmaceuticals, Inc. $6,364.50 04/04/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159433
Principal investigator 1 Mirum Pharmaceuticals, Inc. $2,353.16 04/04/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159437
Principal investigator 1 Mirum Pharmaceuticals, Inc. $4,902.24 04/04/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE) No dispute reported 06/30/2026 1241159442
Principal investigator 1 Gilead Sciences, Inc. $13,140.00 01/07/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide in Children Adolescents with Chronic Hepatitis B Infection No dispute reported 06/30/2026 1229214062